跳至主要内容
临床试验/EUCTR2009-016043-19-DE
EUCTR2009-016043-19-DE进行中(未招募)不适用

Impact of a balanced infusion solution compound of 50% cristalloid and 50% colloid versus a unbalanced infusion solution of 100% cristalloid within a goal-directed hemodynamic protocol on acid-base balance in patients undergoing elective hip replacement surgeryAuswirkung der Anwendung einer balancierten Infusionslösungsmischung aus 50% kolloidaler und 50% kristalloider Lösung versus einer unbalancierten 100% kristalloiden Lösung innerhalb eines zielgerichteten Hämodynamik-Protokolls auf den Säure-Base Haushalt bei Patienten zur elektiven Hüfttotalendoprothese. - HIPSTER

Charité – University Medicine Berlin0 个研究点开始时间: 2010年2月9日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients at the age of 60 and above who want to undergo an elective hip replacement surgery in the center of muscoloskeletal surgery, Campus Charité Mitte, Charité - University Medicine Berlin.
  • - Offered patient information and written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Participation in another trial according to the German Drug Law 30 days prior to and during the study
  • - Lacking willingness to save and hand out pseudonymised data within the study
  • - Accommodation in an institution due to an official or judicial order
  • - (unclear) history of alcohol or substances disabuse
  • - absent knowledge of german language
  • - analphabetism
  • - Allergy to hydroxyethyl starch or other ingredients of the intravenous solutions
  • - for women: Pregnancy or positive pregnancy test within the preoperative screening
  • - operation due to case of emergency, polytrauma or pathologic fracture
  • - only use of regional anesthetics
  • - American Society of Anaesthesiologists (ASA) classification greater than III
  • - peripheral and central edema
  • - AIDS (according to the CDC-classification of HIV-infection: category C)
  • - rheumatoid disease under treatment with Anti-TNF-alpha-Ab and/or high-dose-corticoid-treatment
  • - immunosuppression therapy
  • - history of bleeding tendency (e.g. von-Willebrand-disease, thromobocytopenia)
  • - derailed metabolic disorder (e.g. Diabetes mellitus (Glucose > 300 mg/dl) during the preoperative screening)
  • - known history of electrolyte disturbance (e.g. Hyperkalemia > 5.8 mmol/l, Hypernatriaemia > 155 mmol/l)
  • - known history of acid-base-dysbalances
  • - history of intracranial hemorrhage within one year of participation in the study
  • - neurological or psychiatric disease with limited contractual capability
  • - advanced disease of the oesophagus or upper respiratory tract
  • - operation in the area of the oesophagus or nasopharynx within the last two months
  • - CHF (congestive heart failure) according to (new york heart association) classification - NYHA class IV
  • - liver disease (CHILD B or C cirrhosis, end-stage liver disease (MELD-score greater than 10)
  • - conditions after acute or chronic pancreatititis
  • - renal insufficiency (serum creatinine greater than 2.0 mg/dl or greater than 150 µmol/l or dependency of haemodialysis)

研究者

相似试验